A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Not Applicable

• Conditions: Amphetamine-Related Disorders
• Interventions: Behavioral: CBT- based SMS text messaging intervention; Behavioral: CBT group therapy

• Registration Number: NCT01899313
• Lead Sponsor: California Pacific Medical Center Research Institute

Brief Summary

This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-05-30
• Study First Submitted QC: 2013-07-11
• Study First Posted: 2013-07-15
• Status Verified: 2014-05
• Study Start: 2014-05
• Last Update Submitted: 2014-05-12
• Last Update Posted: 2014-05-14
• Primary Completion: 2015-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• English-speaking adults ≥ 18 years who are seeking treatment for MA addiction.
• Own a cellular phone with SMS text messaging capability and have an unlimited text messaging plan.
• Available to attend CBT therapy groups.
• Agreeable to conditions of the study and signed an informed consent form.

Read More

Exclusion Criteria

• Projected to be unavailable > 12 hours/day to read and send text messages.
• Any medical or psychosocial condition that would preclude safe, useful, or consistent participation,

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
CBT- based SMS text messaging intervention	CBT- based SMS text messaging intervention	cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention
CBT- based SMS text messaging intervention	CBT group therapy	cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention
Placebo Texts	CBT group therapy	Placebo texts will be given instead of interventional texts

Primary Outcome Measures

Name	Time	Method
Proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period	5 weeks	The primary efficacy measure for this study is the difference in proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period. Urine samples will be analyzed for MA by immunoassay with a cutoff of 1,000 ng/mL.

Trial Locations

Locations (2)

New Leaf Treatment Center; 🇺🇸 Lafayette, California, United States

Addiction & Pharmacology Research Laboratory; 🇺🇸 San Francisco, California, United States